Nurix Therapeutics
NRIX
NRIX
172 hedge funds and large institutions have $783M invested in Nurix Therapeutics in 2025 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 60 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4.96% less ownership
Funds ownership: 115.85% → 110.89% (-5%)
18% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 60
22% less capital invested
Capital invested by funds: $1.01B → $783M (-$223M)
Holders
172
Holding in Top 10
1
Calls
$1.12M
Puts
$104K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$9.89M | |
| 3 | +$9.19M | |
| 4 |
Millennium Management
New York
|
+$5.51M |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$4.15M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$14.4M | |
| 3 | -$11.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.2M |
